PharmaSGP Holding SE (PSG.DE)
EUR 24.8
(4.2%)
EUR 24.8
(4.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 22.64 Million | 24.71 Million | 12.24 Million | 15.45 Million | 17.63 Million | 8.42 Million |
| Net Income | 16.39 Million | 11.95 Million | 10.69 Million | 10.64 Million | 16.7 Million | 14.73 Million |
| Depreciation & Amortization | 9.29 Million | 9.25 Million | 3.57 Million | 486 Thousand | 397 Thousand | 387 Thousand |
| Deferred income taxes | 75 Thousand | 194 Thousand | 56 Thousand | -4000.00 | 110 Thousand | 181 Thousand |
| Stock-based compensation | -47 Thousand | 104 Thousand | 21 Thousand | - | - | - |
| Change in working capital | -5.1 Million | 1.14 Million | -3.67 Million | 9.12 Million | -3.13 Million | -4.22 Million |
| Other non-cash items | 24.05 Million | 2.36 Million | 1.65 Million | -4.79 Million | 3.66 Million | -1.88 Million |
| Investing Cash Flow | -866 Thousand | -787 Thousand | -83.45 Million | -898 Thousand | -324 Thousand | -215 Thousand |
| Investments in PPE | -866 Thousand | -787 Thousand | -83.45 Million | -898 Thousand | -433 Thousand | -274 Thousand |
| Acquisitions | - | - | - | - | 109 Thousand | 59 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -813 Thousand | -667 Thousand | -83.36 Million | -478 Thousand | -324 Thousand | 59 Thousand |
| Financing Cash Flow | -13.65 Million | -12.1 Million | 84.04 Million | -95.03 Million | -5.83 Million | -4.3 Million |
| Debt repayment | -8.05 Million | -4.48 Million | -85 Million | -247 Thousand | -264 Thousand | -253 Thousand |
| Dividends payments | -5.87 Million | -5.4 Million | - | -94.83 Million | -5.5 Million | - |
| Common Stock Repurchased | -286 Thousand | - | - | - | - | -4.04 Million |
| Common Stock Issuance | - | - | - | 120 Thousand | - | - |
| Other Financing Activities | 996 Thousand | -2.22 Million | 169.04 Million | -322 Thousand | -339 Thousand | -4.05 Million |
| Accounts receivables | -1.39 Million | -1.21 Million | 2.88 Million | 1.41 Million | -3.11 Million | -1.78 Million |
| Accounts payables | 1.03 Million | 4.46 Million | -5.47 Million | 8.89 Million | 3.11 Million | - |
| Inventory | -3.11 Million | -2.81 Million | -1.14 Million | -940 Thousand | 1.17 Million | - |
| Other working capital | -1.63 Million | 723 Thousand | 51 Thousand | -252 Thousand | -4.3 Million | -4.22 Million |
| Cash at beginning of period | 32.64 Million | 20.82 Million | 8 Million | 88.47 Million | 77 Million | 73.1 Million |
| Cash at end of period | 40.76 Million | 32.64 Million | 20.82 Million | 8 Million | 88.47 Million | 77 Million |
| Capital Expenditure | -866 Thousand | -787 Thousand | -83.45 Million | -898 Thousand | -433 Thousand | -274 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 8.12 Million | 11.81 Million | 12.82 Million | -80.47 Million | 11.46 Million | 3.9 Million |
| Free Cash Flow | 21.78 Million | 23.92 Million | -71.21 Million | 14.56 Million | 17.19 Million | 8.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.11 Million | 4.55 Million | 16.39 Million | 4.74 Million | 4.78 Million | 4.01 Million |
| Depreciation & Amortization | 2.34 Million | 2.33 Million | 9.29 Million | 2.36 Million | 2.34 Million | 2.35 Million |
| Deferred income taxes | - | - | 75 Thousand | 75 Thousand | - | - |
| Stock-based compensation | - | - | -47 Thousand | -47 Thousand | - | - |
| Change in working capital | -8.89 Million | -1.75 Million | -5.1 Million | 282 Thousand | -1.86 Million | -3.31 Million |
| Other non-cash items | 1.07 Million | 6.02 Million | 24.05 Million | 5.24 Million | 1.76 Million | 1.4 Million |
| Investing Cash Flow | -234 Thousand | -648 Thousand | -866 Thousand | -221 Thousand | -232 Thousand | -178 Thousand |
| Investments in PPE | -234 Thousand | -648 Thousand | -866 Thousand | -221 Thousand | -232 Thousand | -178 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -220 Thousand | -625 Thousand | -813 Thousand | -216 Thousand | -220 Thousand | -174 Thousand |
| Financing Cash Flow | -4.75 Million | 251 Thousand | -13.65 Million | -3.73 Million | -6.77 Million | -5.02 Million |
| Debt repayment | -4.12 Million | -115 Thousand | -8.05 Million | -4.02 Million | -29 Thousand | -4.1 Million |
| Dividends payments | - | - | -5.87 Million | - | -5.87 Million | - |
| Common Stock Repurchased | - | - | -286 Thousand | - | -3000.00 | -145 Thousand |
| Common Stock Issuance | - | - | - | - | 5.9 Million | - |
| Other Financing Activities | -3.63 Million | 366 Thousand | 996 Thousand | 399 Thousand | -6.77 Million | -4.87 Million |
| Accounts receivables | -1.69 Million | -5.11 Million | -1.39 Million | 915 Thousand | -779 Thousand | -423 Thousand |
| Accounts payables | -7.02 Million | 4.49 Million | 1.03 Million | -296 Thousand | -870 Thousand | -1.28 Million |
| Inventory | 462 Thousand | 34 Thousand | -3.11 Million | -477 Thousand | -122 Thousand | -1.18 Million |
| Other working capital | -633 Thousand | -1.17 Million | -1.63 Million | 140 Thousand | -95 Thousand | -420 Thousand |
| Cash at beginning of period | 46.27 Million | 40.76 Million | 32.64 Million | 36.59 Million | 36.57 Million | 37.31 Million |
| Cash at end of period | 40.39 Million | 46.27 Million | 40.76 Million | 40.76 Million | 36.59 Million | 36.57 Million |
| Capital Expenditure | -234 Thousand | -648 Thousand | -866 Thousand | -221 Thousand | -232 Thousand | -178 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.87 Million | 5.5 Million | 8.12 Million | 4.17 Million | 24 Thousand | -738 Thousand |
| Free Cash Flow | -1.12 Million | 5.25 Million | 21.78 Million | 7.9 Million | 6.79 Million | 4.28 Million |
ALBLD
3379
MCB
TOSCF
ARRPY
002679